Investor profile for Ren Life Sciences: stage-based planning range, investment stages, sector focus, portfolio companies, sources, and verification status. Part of the Venture Capital Tracker directory.

VC fund profile · evidence-aware directory data

Ren Life Sciences stages, portfolio and investment profile

Specialist investment manager backing European life-sciences businesses with strong scientific foundations and clinical potential. Its second vehicle, Ren Life Sciences Partners II, closed at €375 million in September 2026, according to placement agent Pacenote Capital.

Keep track of Ren Life Sciences

Save this profile to your VCT watchlist for a quick return.

View watchlist

Stage-based planning range

$100K–$1M

This is a planning range inferred from stage coverage, not a firm-disclosed check size.

Methodology: Stage bucket inferred from the rounds a fund leads or invests in.

No firm-specific check-size disclosure is recorded.

Source link not recorded Confidence: 25% Verified: November 18, 2026 View methodology

Investment stages

Leads: Not recorded

Participates: Not recorded

Sector focus

Not recorded

Geography

European investment mandate

Founded Not recorded

Fund size / AUM

Not recorded

A separate fund-size evidence record is not yet available.

Portfolio in our directory

None yet

Linked startup profiles

Recent tracked investment

Not recorded

No dated round explicitly links this fund.

Rounds they lead

Rounds they invest

Last verified: 2026-11-18T15:12:00.000Z. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.